drugset / Trial / NCT00224016
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the safety and effectiveness of an anticholinergic drug treatment administered by transdermal patch to treat overactive bladder in children who have a neurological condition (e.g. spina bifida) that contributes to their overactive bladder.
Timeline
- Start
- 2004-12
- Primary completion
- 2007-04
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxybutynin | Small molecule | 1.3 mg | Other |
| Comparator | Oxybutynin | Small molecule | 2.6 mg | Other |
| Comparator | Oxybutynin | Small molecule | 3.9 mg | Other |
| Comparator | Oxybutynin | Small molecule | 5 mg | Other |
| Comparator | Oxybutynin | Small molecule | 10 mg | Other |
| Comparator | Oxybutynin | Small molecule | 15 mg | Other |